These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38290537)

  • 1. Individualized Homeopathic and Organopathic Supportive Management of Sickle Cell Disorder: A Case Series of Six Patients from a Particularly Vulnerable Tribal Group in India.
    Nambison NKM; Sharma N; Dwivedi AD; Chakravarty N
    Homeopathy; 2024 Jan; ():. PubMed ID: 38290537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Chourasia S; Kumar R; Singh MPSS; Vishwakarma C; Gupta AK; Shanmugam R
    Hemoglobin; 2020 Nov; 44(6):391-396. PubMed ID: 33222570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
    Luo L; King AA; Carroll Y; Baumann AA; Brambilla D; Carpenter CR; Colla J; Gibson RW; Gollan S; Hall G; Klesges L; Kutlar A; Lyon M; Melvin CL; Norell S; Mueller M; Potter MB; Richesson R; Richardson LD; Ryan G; Siewny L; Treadwell M; Zun L; Armstrong-Brown J; Cox L; Tanabe P
    JMIR Res Protoc; 2021 Apr; 10(4):e24818. PubMed ID: 33861209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn Screening for Sickle Cell Disease Among Tribal Populations in the States of Gujarat and Madhya Pradesh in India: Evaluation and Outcome Over 6 Years.
    Thaker P; Colah RB; Patel J; Raicha B; Mistry A; Mehta V; Italia Y; Desai S; Dave K; Shanmugam R; Ghosh K; Mukherjee MB
    Front Med (Lausanne); 2021; 8():731884. PubMed ID: 35242766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India.
    Desai G; Anand A; Shah P; Shah S; Dave K; Bhatt H; Desai S; Modi D
    J Health Popul Nutr; 2017 Jan; 36(1):3. PubMed ID: 28109314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
    Babu BV; Sharma Y; Sridevi P; Surti SB; Bhat D; Ranjit M; Sudhakar G; Sarmah J
    Hemoglobin; 2023 Nov; 47(6):227-236. PubMed ID: 38189147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals.
    Yadav R; Lazarus M; Ghanghoria P; Singh M; Gupta RB; Kumar S; Sharma RK; Shanmugam R
    Hematology; 2016 Oct; 21(9):558-63. PubMed ID: 27077770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell diseases: What can nuclear medicine offer?
    Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
    Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease in Indian tribal population: Findings of a multi-centre Indian SCD registry.
    Sharma Y; Bhat D; Sridevi P; Surti SB; Ranjit M; Sarmah J; Sudhakar G; Babu BV
    Blood Cells Mol Dis; 2024 Jul; 109():102873. PubMed ID: 39024737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral health workers' knowledge and experience related to sickle cell disease: an in-depth interview study in six tribal-dominated districts of India.
    Babu BV; Sridevi P; Surti SB; Ranjit M; Bhat D; Sarmah J; Sudhakar G; Sharma Y
    J Community Genet; 2022 Jun; 13(3):329-338. PubMed ID: 35103923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse Models of Pain in Sickle Cell Disease.
    Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
    Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management.
    Uwaezuoke SN; Ayuk AC; Ndu IK; Eneh CI; Mbanefo NR; Ezenwosu OU
    J Pain Res; 2018; 11():3141-3150. PubMed ID: 30588066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
    Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010155. PubMed ID: 26684281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia.
    Albohassan H; Ammen M; Alomran AA; Bu Shehab H; Al Sakkak H; Al Bohassan A
    Cureus; 2022 Nov; 14(11):e31527. PubMed ID: 36540486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
    Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL
    Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Sickle cell disease: Causes, symptoms, and treatment options.
    Elendu C; Amaechi DC; Alakwe-Ojimba CE; Elendu TC; Elendu RC; Ayabazu CP; Aina TO; Aborisade O; Adenikinju JS
    Medicine (Baltimore); 2023 Sep; 102(38):e35237. PubMed ID: 37746969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.